Celsion Corporation Company Profile (NASDAQ:CLSN)

About Celsion Corporation

Celsion Corporation logoCelsion Corporation is an oncology drug development company. The Company's product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for treatment of recurrent chest wall breast cancer (the DIGNITY Study). Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers. It has over three platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, including Lysolipid Thermally Sensitive Liposomes, a heat sensitive liposomal based dosage form that targets disease with known therapeutics in the presence of mild heat; TheraPlas, a nucleic acid-based treatment for local transfection of therapeutic plasmids, and TheraSilence, a systemic dosage form for lung directed anti-cancer ribonucleic acid (RNA).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CLSN
  • CUSIP:
Key Metrics:
  • Previous Close: $0.25
  • 50 Day Moving Average: $0.3612
  • 200 Day Moving Average: $0.8469
  • 52-Week Range: $0.19 - $1.78
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.39
  • P/E Growth: 0.0000
  • Market Cap: $5.93M
  • Outstanding Shares: 26,078,000
  • Beta: 1.53
Profitability:
  • Net Margins: -4,390.50%
  • Return on Equity: -139.38%
  • Return on Assets: -50.47%
Debt:
  • Current Ratio: 0.93%
  • Quick Ratio: 0.93%
Additional Links:
Companies Related to Celsion Corporation:

Analyst Ratings

Consensus Ratings for Celsion Corporation (NASDAQ:CLSN) (?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $3.50 (1,473.03% upside)

Analysts' Ratings History for Celsion Corporation (NASDAQ:CLSN)
Show:
DateFirmActionRatingPrice TargetDetails
11/14/2016HC WainwrightReiterated RatingBuyView Rating Details
11/10/2016Maxim GroupDowngradeBuy -> HoldView Rating Details
11/24/2015Cantor FitzgeraldReiterated RatingNot Available -> BuyView Rating Details
7/13/2015BTIG ResearchInitiated CoverageBuy$10.00View Rating Details
4/16/2015Griffin SecuritiesSet Price TargetBuy$7.00View Rating Details
(Data available from 2/21/2015 forward)

Earnings

Earnings History for Celsion Corporation (NASDAQ:CLSN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/28/2017        
8/15/2016Q2($0.21)($0.19)ViewListenView Earnings Details
5/16/2016Q116($0.21)($0.24)ViewListenView Earnings Details
3/30/2016Q415($0.24)($0.24)ViewListenView Earnings Details
11/5/2015Q315($0.26)($0.20)ViewN/AView Earnings Details
8/10/2015Q215($0.31)($0.27)ViewListenView Earnings Details
5/12/2015Q1($0.33)($0.34)ViewN/AView Earnings Details
3/12/2015($0.36)($0.32)ViewN/AView Earnings Details
11/12/2014($0.30)($0.35)ViewN/AView Earnings Details
8/7/2014Q214($0.32)($0.38)ViewN/AView Earnings Details
5/8/2014($0.24)($0.33)ViewN/AView Earnings Details
3/13/2014($0.28)($0.19)ViewN/AView Earnings Details
11/12/2013Q3($0.23)($0.30)$0.13 millionViewListenView Earnings Details
8/8/2013Q2 2013($0.07)$0.01$0.13 millionViewN/AView Earnings Details
5/9/2013Q1 2013($0.16)($0.12)ViewN/AView Earnings Details
11/12/2012Q312($0.17)($0.18)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Celsion Corporation (NASDAQ:CLSN)
Current Year EPS Consensus Estimate: $-0.8500 EPS
Next Year EPS Consensus Estimate: $-0.5700 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.22)($0.22)($0.22)
Q2 20161($0.20)($0.20)($0.20)
Q3 20161($0.17)($0.17)($0.17)
Q4 20161($0.17)($0.17)($0.17)
Q1 20171($0.18)($0.18)($0.18)
Q2 20171($0.13)($0.13)($0.13)
Q3 20171($0.10)($0.10)($0.10)
Q4 20171($0.10)($0.10)($0.10)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Celsion Corporation (NASDAQ:CLSN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Celsion Corporation (NASDAQ:CLSN)
Insider Ownership Percentage: 7.96%
Institutional Ownership Percentage: 10.74%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/15/2017Alberto R Martinez JrDirectorBuy45,000$0.22$9,900.00View SEC Filing  
11/14/2016Alberto R Martinez JrDirectorBuy10,000$0.86$8,600.00View SEC Filing  
11/11/2016Alberto R Martinez JrDirectorBuy10,000$0.91$9,100.00View SEC Filing  
10/7/2016Michael H TardugnoChairmanBuy10,000$1.14$11,400.00View SEC Filing  
8/16/2016Alberto R Martinez JrDirectorBuy5,000$1.25$6,250.00View SEC Filing  
6/17/2016Alberto R Martinez JrDirectorBuy5,000$1.35$6,750.00View SEC Filing  
6/16/2016Michael H TardugnoCEOBuy7,500$1.35$10,125.00View SEC Filing  
2/19/2016Michael H TardugnoCEOBuy3,000$1.27$3,810.00View SEC Filing  
2/17/2016Michael H TardugnoCEOBuy2,000$1.27$2,540.00View SEC Filing  
2/16/2016Alberto R Martinez JrDirectorBuy5,000$1.16$5,800.00View SEC Filing  
2/16/2016Michael H TardugnoCEOBuy4,500$1.20$5,400.00View SEC Filing  
2/12/2016Michael H TardugnoCEOBuy6,500$1.13$7,345.00View SEC Filing  
12/3/2015Egwu, Inc. Fka Egen, Inc.Major ShareholderSell5,556$2.08$11,556.48View SEC Filing  
11/30/2015Egwu, Inc. Fka Egen, Inc.Major ShareholderSell20,000$2.15$43,000.00View SEC Filing  
9/8/2015Egwu, Inc. Fka Egen, Inc.Major ShareholderSell10,000$2.11$21,100.00View SEC Filing  
8/17/2015Egwu, Inc. Fka Egen, Inc.Major ShareholderSell10,000$2.19$21,900.00View SEC Filing  
8/13/2015Egwu, Inc. Fka Egen, Inc.Major ShareholderSell20,000$2.23$44,600.00View SEC Filing  
5/13/2015Alberto R Martinez JrDirectorBuy5,000$2.50$12,500.00View SEC Filing  
12/18/2014Frederick J FritzDirectorBuy4,000$2.34$9,360.00View SEC Filing  
11/13/2014Robert W HooperDirectorBuy4,000$2.50$10,000.00View SEC Filing  
8/15/2014Alberto R Martinez JrDirectorBuy5,000$3.12$15,600.00View SEC Filing  
8/15/2014Michael H TardugnoCEOBuy4,000$3.12$12,480.00View SEC Filing  
8/14/2014Frederick J FritzDirectorBuy4,000$3.20$12,800.00View SEC Filing  
6/26/2014Alberto R Martinez JrDirectorBuy5,000$3.36$16,800.00View SEC Filing  
6/11/2014Michael H TardugnoCEOBuy5,000$3.20$16,000.00View SEC Filing  
3/14/2014Frederick FritzDirectorBuy2,500$3.86$9,650.00View SEC Filing  
3/14/2014Michael TardugnoCEOBuy4,000$3.84$15,360.00View SEC Filing  
11/19/2013Michael TardugnoCEOBuy2,800$3.59$10,052.00View SEC Filing  
11/15/2013Frederick FritzDirectorBuy3,000$3.80$11,400.00View SEC Filing  
8/16/2013Frederick FritzDirectorBuy10,000$1.09$10,900.00View SEC Filing  
8/16/2013Michael TardugnoCEOBuy5,000$1.08$5,400.00View SEC Filing  
6/12/2013Michael H TardugnoCEOBuy10,000$1.35$13,500.00View SEC Filing  
5/21/2013Alberto R Martinez JrDirectorBuy5,000$0.93$4,650.00View SEC Filing  
5/13/2013Alberto R Martinez JrDirectorBuy5,000$0.96$4,800.00View SEC Filing  
5/10/2013Alberto R Martinez JrDirectorBuy5,000$0.92$4,600.00View SEC Filing  
3/20/2013Alberto R Martinez JrDirectorBuy3,750$1.06$3,975.00View SEC Filing  
12/10/2012Max LinkDirectorBuy14,000$7.60$106,400.00View SEC Filing  
11/15/2012Robert W HooperDirectorBuy11,600$5.20$60,320.00View SEC Filing  
9/14/2012Michael H TardugnoCEOBuy5,000$5.03$25,150.00View SEC Filing  
9/10/2012Robert W HooperDirectorBuy10,000$4.95$49,500.00View SEC Filing  
8/29/2012Robert W HooperDirectorBuy2,500$4.65$11,625.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Celsion Corporation (NASDAQ:CLSN)
DateHeadline
News IconCelsion Corporation (CLSN) Has Revealed It All In Its Chart - NY Stock News (NASDAQ:CLSN)
nystocknews.com - February 21 at 3:46 PM
News IconAnalysts Near-Term outlook: Platform Specialty Products Corporation (PAH), Celsion Corporation (CLSN) - The USA Commerce (NASDAQ:CLSN)
theusacommerce.com - February 21 at 3:46 PM
News IconTaking a Look at the Data Behind Celsion Corporation (CLSN) - StockNewsJournal (NASDAQ:CLSN)
stocknewsjournal.com - February 21 at 3:46 PM
finance.yahoo.com logoCelsion Corp. Cancer Medications Insider Buying and Analysis (NASDAQ:CLSN)
finance.yahoo.com - February 21 at 3:46 PM
News IconCelsion Corporation (CLSN): How technical indicators have come out? - Post Analyst (NASDAQ:CLSN)
postanalyst.com - February 20 at 4:07 PM
News IconThe Technicals For Celsion Corporation (CLSN) Have Been Dissected (Brutally) - NY Stock News (NASDAQ:CLSN)
nystocknews.com - February 20 at 4:07 PM
News IconPast 3 Quarter Report of New Residential Investment Corporation (NYSE:NRZ) (NASDAQ:CLSN)
fairydetox.org - February 19 at 4:03 PM
News IconCNN reporter to Trump: 'I don't hate you' (NASDAQ:CLSN)
brassale.net - February 19 at 4:03 PM
News IconCelsion Corporation (NASDAQ:CLSN) Reports Issuance Of New Patents For ThermoDox® (NASDAQ:CLSN)
www.financialstrend.com - February 17 at 5:51 PM
News IconDirector of Celsion Corporation (NASDAQ:CLSN), Martinez Alberto R Jr, buys 45,000 shares worth $9,675 (NASDAQ:CLSN)
empowerednews.net - February 16 at 4:25 PM
investing.com logoU.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.52% (NASDAQ:CLSN)
www.investing.com - February 16 at 10:58 AM
us.rd.yahoo.com logoCelsion Corporation Announces $5.0 Million Public Offering (NASDAQ:CLSN)
us.rd.yahoo.com - February 16 at 10:58 AM
biz.yahoo.com logoCELSION CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:CLSN)
biz.yahoo.com - February 16 at 10:58 AM
News IconStock Chatter: Celsion Corporation (NASDAQ:CLSN) Price Target Update - Rockville Register (NASDAQ:CLSN)
rockvilleregister.com - February 14 at 10:11 PM
News IconCan the next move of Celsion Corp. (NASDAQ:CLSN) be predicted? - The Oracle Examiner (NASDAQ:CLSN)
oracleexaminer.com - February 10 at 9:37 PM
News IconMarket Scout: Checking the Levels for Celsion Corp. (CLSN) - Davidson Register (NASDAQ:CLSN)
davidsonregister.com - February 10 at 9:37 PM
News IconWhat's Happening To These Stocks? – WisdomTree Investments, Inc. (WETF), Celsion Corporation (CLSN) - Post Analyst (NASDAQ:CLSN)
postanalyst.com - February 10 at 9:37 PM
News IconTrading Sheet: Tracking Technicals for Celsion Corp. (CLSN) - Sherwood Daily (NASDAQ:CLSN)
sherwooddaily.com - February 4 at 2:40 AM
News IconMA Watch on Shares of Celsion Corp. (CLSN) - Sherwood Daily (NASDAQ:CLSN)
sherwooddaily.com - February 2 at 4:40 PM
News IconCelsion Corporation (NASDAQ:CLSN) Stock ABR At 1.67 - Stock Observer (NASDAQ:CLSN)
www.thestockobserver.com - February 2 at 2:42 AM
News IconCheap Stock, But is it a Bargain: Celsion Corporation (NASDAQ:CLSN) - Prospect Journal (NASDAQ:CLSN)
prospectjournal.com - January 31 at 9:48 PM
News IconHoning in on Shares of Celsion Corporation (NASDAQ:CLSN) - Prospect Journal (NASDAQ:CLSN)
prospectjournal.com - January 31 at 9:48 PM
realistinvestor.com logoCelsion Corporation (NASDAQ:CLSN) EPS Projection At $-0.095 - RealistInvestor.com (NASDAQ:CLSN)
www.realistinvestor.com - January 31 at 4:47 PM
News IconInvestor Corner: Checking the Charts for Celsion Corp. (CLSN) - Sherwood Daily (NASDAQ:CLSN)
sherwooddaily.com - January 30 at 10:16 PM
News IconNotable Stock For Under $5: Celsion Corporation (NASDAQ:CLSN) - Prospect Journal (NASDAQ:CLSN)
prospectjournal.com - January 30 at 10:16 PM
News IconAre Insiders Bumping Up Their Positions in Celsion Corporation (NASDAQ:CLSN) - Wall Street Beacon (NASDAQ:CLSN)
wsbeacon.com - January 30 at 10:16 PM
News IconCelsion, Corp. (NASDAQ:CLSN) Up 30% Following Announcement of Continuing Positive Data From OVATION Study - Nelson Observer (NASDAQ:CLSN)
nelsonobserver.com - January 30 at 6:31 AM
4-traders.com logoCELSION CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) (NASDAQ:CLSN)
www.4-traders.com - January 27 at 10:44 PM
News IconCelsion Corporation (NASDAQ:CLSN) Stock ABR At 1.67 | Stock ... - Stock Observer (NASDAQ:CLSN)
www.thestockobserver.com - January 27 at 5:42 PM
News IconLooking at the Gauges on Celsion Corp. (CLSN) - Sherwood Daily (NASDAQ:CLSN)
sherwooddaily.com - January 27 at 5:42 PM
biz.yahoo.com logoCELSION CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:CLSN)
biz.yahoo.com - January 27 at 5:42 PM
News IconSell-side Taking Aim at Shares of Celsion Corporation (NASDAQ:CLSN) - Aiken Advocate (NASDAQ:CLSN)
aikenadvocate.com - January 26 at 5:22 PM
News IconShares in View: Celsion Corp. (CLSN) - Sherwood Daily (NASDAQ:CLSN)
sherwooddaily.com - January 20 at 5:29 PM
News IconCelsion announces issuance of two new patents for ThermoDox (NASDAQ:CLSN)
www.dotmed.com - January 19 at 10:36 PM
us.rd.yahoo.com logoCelsion to Present Two Posters on its GEN-1 IL-12 Gene-Mediated Immunotherapy at the ASCO-SITC Clinical Immuno-Oncology Symposium (NASDAQ:CLSN)
us.rd.yahoo.com - January 19 at 10:36 PM
News IconMoving Averages in Focus on Shares of Celsion Corp. (CLSN) - Sherwood Daily (NASDAQ:CLSN)
sherwooddaily.com - January 19 at 5:35 PM
capitalcube.com logoETFs with exposure to Celsion Corp. : January 19, 2017 (NASDAQ:CLSN)
www.capitalcube.com - January 19 at 5:35 PM
globenewswire.com logoCelsion Corporation Announces Issuance of Two New Patents for ThermoDox® - GlobeNewswire (press release) (NASDAQ:CLSN)
globenewswire.com - January 19 at 2:42 AM
News IconCelsion Corporation (CLSN) Valuation According To Analysts (NASDAQ:CLSN)
flapship.com - January 18 at 4:42 PM
us.rd.yahoo.com logoCelsion Corporation Announces Issuance of Two New Patents for ThermoDox® (NASDAQ:CLSN)
us.rd.yahoo.com - January 18 at 4:42 PM
us.rd.yahoo.com logo8:03 am Celsion announces USPTO issuance of two new patents covering ThermoDox (NASDAQ:CLSN)
us.rd.yahoo.com - January 18 at 4:42 PM
streetinsider.com logoCelsion (CLSN) Posts Positive Results in Phase Ib GEN-1 Combo Study - StreetInsider.com (NASDAQ:CLSN)
www.streetinsider.com - January 17 at 10:10 PM
streetinsider.com logoPre-Open Stock Movers 01/17: (FWP) (CLSN) (GEVO) Higher; (ADHD) (CBK) (UEC) Lower (more...) (NASDAQ:CLSN)
www.streetinsider.com - January 17 at 5:10 PM
streetinsider.com logoPre-Open Stock Movers 01/17: (FWP) (CLSN) (GEVO) Higher; (ADHD) (CBK) (UEC) Lower (more...) (NASDAQ:CLSN)
www.streetinsider.com - January 17 at 5:10 PM
4-traders.com logoNetworkNewsBreaks – Celsion (NASDAQ: CLSN) Shares Hike on Positive Data from the OVATION Study (NASDAQ:CLSN)
www.4-traders.com - January 17 at 5:10 PM
4-traders.com logoNetworkNewsBreaks – Celsion (NASDAQ: CLSN) Shares Hike on Positive Data from the OVATION Study (NASDAQ:CLSN)
www.4-traders.com - January 17 at 5:10 PM
finance.yahoo.com logo8:10 am Celsion announces data from the fourth cohort of patients in its OVATION study; expects to complete enrollment in the OVATION Study this quarter (NASDAQ:CLSN)
finance.yahoo.com - January 17 at 5:10 PM
finance.yahoo.com logo8:10 am Celsion announces data from the fourth cohort of patients in its OVATION study; expects to complete enrollment in the OVATION Study this quarter (NASDAQ:CLSN)
finance.yahoo.com - January 17 at 5:10 PM
finance.yahoo.com logoCelsion Announces Continuing Positive Data from the OVATION Study in Newly Diagnosed Advanced Ovarian Cancer Patients (NASDAQ:CLSN)
finance.yahoo.com - January 17 at 9:02 AM
News IconCheap Stock, But is it a Bargain: Celsion Corporation (NASDAQ ... - Prospect Journal (NASDAQ:CLSN)
prospectjournal.com - January 16 at 9:22 PM

Social

What is Celsion Corporation's stock symbol?

Celsion Corporation trades on the NASDAQ under the ticker symbol "CLSN."

Where is Celsion Corporation's stock going? Where will Celsion Corporation's stock price be in 2017?

2 analysts have issued 1-year price targets for Celsion Corporation's shares. Their predictions range from $3.00 to $4.00. On average, they expect Celsion Corporation's share price to reach $3.50 in the next year.

When will Celsion Corporation announce their earnings?

Celsion Corporation is scheduled to release their next quarterly earnings announcement on Tuesday, March, 28th 2017.

Who owns Celsion Corporation stock?

Celsion Corporation's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Mitchell P Kopin (4.99%) and Renaissance Technologies LLC (2.63%). Company insiders that own Celsion Corporation stock include Alberto R Martinez Jr, Egwu, Inc Fka Egen, Inc and Michael H Tardugno.

Who bought Celsion Corporation stock? Who is buying Celsion Corporation stock?

Celsion Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC. Company insiders that have bought Celsion Corporation stock in the last two years include Alberto R Martinez Jr and Michael H Tardugno.

How do I buy Celsion Corporation stock?

Shares of Celsion Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Celsion Corporation stock cost?

One share of Celsion Corporation stock can currently be purchased for approximately $0.22.

Celsion Corporation (NASDAQ:CLSN) Chart for Tuesday, February, 21, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Celsion Corporation (NASDAQ:CLSN)

Earnings History Chart

Earnings by Quarter for Celsion Corporation (NASDAQ:CLSN)

Dividend History Chart

Dividend Payments by Quarter for Celsion Corporation (NASDAQ:CLSN)

Last Updated on 2/21/2017 by MarketBeat.com Staff